|
|
||||
16/04/2026 07:30
Kering:
PRESS RELEASE
April 16, 2026
RECONKERING
TRUE LUXURY. NEXT LUXURY.
Kering unveils its strategic vision to reignite desirability, reinforce operational excellence, and...
Lire...
16/04/2026 07:30
MAUREL & PROM : Inside Information / Other news releases
Paris, 16 April 2026
No. 1326
Q1 2026 activity
• M&P working interest production in Q1 2026: 37,444 boepd, up 7% compared with Q4
2025
o M&P working...
Lire...
Q3 FY26 Sales
Press Release – Paris, 16 April 2026
IMPROVING MOMENTUM WITH STABLE ORGANIC NET SALES IN Q3 IN A
VOLATILE CONTEXT
Q3 FY26 ORGANIC NET SALES 0.1% 14.6% REPORTED
YTD ORGANIC NET SALES 4.4% 14.8%...
Lire...
16/04/2026 07:00
EQS-News: FUCHS presents its new strategy – “FOCUS TO WIN” on the path to its 100th anniversary
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: FUCHS SE
/ Key words: Miscellaneous
br/
FUCHS presents its new strategy – “FOCUS TO WIN” on the path to its 100th anniversary br/br/
16.04.2026 / 07:00...
Lire...
16/04/2026 07:00
EQS-News: NFON confirms preliminary results for 2025 – profitability improves, AI solutions drive business growth
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: NFON AG
/ Key words: Annual Report
br/
NFON confirms preliminary results for 2025 – profitability improves, AI solutions drive business growth br/br/
16.04.2026 /...
Lire...
16/04/2026 07:00
BioVersys AG : BioVersys announces first patient first visit in HABP/VABP pivotal Phase 3 RIV-TARGET trial of BV100
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= cellpadding= cellspacing= trtd
pBioVersys AG / Key words: Studybr/
BioVersys announces first patient first visit in HABP/VABP pivotal Phase 3 RIVTARGET trial of BV100 br/br/span16Apr2026 / 07:00...
Lire...
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
DocMorris AG
/ Key words: AGMEGM
br/
DocMorris publishes invitation to the Annual General Meeting br/br/
16.04.2026 / 07:00 CET/CESTbr/br//p
hr/divpFrauenfeld, 16 April...
Lire...
16/04/2026 06:58
DocMorris AG : DocMorris achieves strong revenue growth in Q1 2026 – on track for EBITDA break-even
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
pDocMorris AG / Key words: Quarterly / Interim Statementbr/
DocMorris achieves strong revenue growth in Q1 2026 – on track for EBITDA breakeven br/br/
16Apr2026 / 06:58 CET/CESTbr/
Release of an ad hoc...
Lire...
16/04/2026 06:30
VAT Group AG : VAT Media Release on Q1 2026 Trading Update
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
pVAT Group AG / Key words: Quarter Results/Quarterly / Interim Statementbr/
VAT Media Release on Q1 2026 Trading Update br/br/
16Apr2026 / 06:30 CET/CESTbr/
Release of an ad hoc announcement pursuant to Art. 53...
Lire...
|
|
||||